Back to Search
MICHAEL PINCUS, D.O.
D.O.
Rheumatology Physician
NPI: 1376741785IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
243537(MA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
243537(MA)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEO MEDICINE
Class of 2007
Research & Publications (20)
Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
PMID 15353372·Front Biosci·2004
7-preclinical
Conformational effects of a common codon 751 polymorphism on the C-terminal domain of the xeroderma pigmentosum D protein.
PMID 19661678·J Carcinog·2009
8-other
IgG anti-cardiomyocyte antibodies in giant cell myocarditis.
PMID 18316787·Ann Clin Lab Sci·2008
5-case
Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells.
PMID 18066549·Cancer Chemother Pharmacol·2008
8-other
Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis.
PMID 18988935·Ann Clin Lab Sci·2008
5-case
Early risk factors for miscarriage: a prospective cohort study in pregnant women.
PMID 18616898·Reprod Biomed Online·2008
8-other
Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
PMID 18316782·Ann Clin Lab Sci·2008
7-preclinical
Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
PMID 18193092·Oncogene·2008
7-preclinical
The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells.
PMID 18931881·Ann Surg Oncol·2008
8-other
Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.
PMID 18803764·Clin Exp Immunol·2008
4-observational
Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.
PMID 18007958·Cancer Ther·2007
8-other
The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.
PMID 17569632·Front Biosci·2007
7-preclinical
Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein.
PMID 17899335·Protein J·2007
8-other
Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes.
PMID 16720323·Front Biosci·2006
7-preclinical
PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo.
PMID 16688716·Int J Cancer·2006
7-preclinical
Novel mutations of epidermal growth factor receptor in localized prostate cancer.
PMID 16720329·Front Biosci·2006
8-other
The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosis.
PMID 15722169·Adv Drug Deliv Rev·2005
6-review
Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
PMID 16086581·Biochemistry·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 41 MALL RD
BURLINGTON, MA 01805 - Phone
- (781) 744-8000
Quick Facts
- NPI
- 1376741785
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile